Analytical Data
-
基因名
MEF2A
- Application
-
别名
MEF2A；MEF2；Myocyte-specific enhancer factor 2A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q02078-5
-
表达区间
1-499aa
-
氨基酸序列
MGRKKIQITR IMDERNRQVT FTKRKFGLMK KAYELSVLCD CEIALIIFNS SNKLFQYAST DMDKVLLKYT EYNEPHESRT NSDIVEALNK KEHRGCDSPD PDTSYVLTPH TEEKYKKINE EFDNMMRNHK IAPGLPPQNF SMSVTVPVTS PNALSYTNPG SSLVSPSLAA SSTLTDSSML SPPQTTLHRN VSPGAPQRPP STGNAGGMLS TTDLTVPNGA GSSPVGNGFV NSRASPNLIG ATGANSLGKV MPTKSPPPPG GGNLGMNSRK PDLRVVIPPS SKGMMPPLNT QRISSSQATQ PLATPVVSVT TPSLPPQGLV YSAMPTAYNT DYSLTSADLS ALQGFNSPGM LSLGQVSAWQ QHHLGQAALS SLVAGGQLSQ GSNLSINTNQ NISIKSEPIS PPRDRMTPSG FQQQQQQQQQ QQPPPPPQPQ PQPPQPQPRQ EMGRSPVDSL SSSSSSYDGS DREDPRGDFH SPIVLGRPPN TEDRESPSVK RMRMDAWVT
-
分子量
55 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MEF2A (Myocyte Enhancer Factor 2A) is a member of the MEF2 family of transcription factors, which play crucial roles in muscle development, differentiation, and cellular response to stress. Research into MEF2A has gained significant attention due to its implications in various biological processes, including cardiogenesis, neurogenesis, and the regulation of gene expression in response to physiological stimuli. Abnormalities in MEF2A function have been linked to multiple diseases, such as cardiac hypertrophy, neurodegenerative disorders, and cancer. As MEF2A is involved in pathways that govern the survival and apoptosis of cells, understanding its structure and function is critical for elucidating its role in disease mechanisms. Recombinant MEF2A proteins are generated to study their biological functions, interaction partners, and regulatory mechanisms in vitro and in vivo. By producing and characterizing these proteins, researchers aim to provide insights into the molecular pathways involving MEF2A, identify potential therapeutic targets, and develop strategies for modulating its activity in disease contexts. Given its central role in numerous cellular processes and its potential as a therapeutic target, the study of MEF2A recombinant proteins constitutes an essential avenue of biomedical research, contributing to our understanding of fundamental cellular mechanisms and potential interventions in related pathologies.
